Suppr超能文献

迈向单价降解剂的合理设计:从细胞周期蛋白K降解剂中汲取的经验教训。

Towards the Rational Design of Monovalent Degraders: Lessons Learnt from Cyclin K Degraders.

作者信息

Thomas Katie L, Bellenie Benjamin R, Rossanese Olivia W

机构信息

Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K..

出版信息

Chimia (Aarau). 2025 Mar 26;79(3):162-166. doi: 10.2533/chimia.2025.162.

Abstract

Monovalent degraders can enhance pre-existing surface complementarity between a target protein and a ligase to induce target degradation via the proteasome. For the most part, degraders have been discovered serendipitously and structure-activity relationship (SAR) studies have been limited, making it difficult to rationally design new compounds. Here we discuss how work on the SAR of cyclin K degraders demonstrates that a broad range of compounds can stabilise protein-protein interactions to induce degradation and how it lays the foundation for further monovalent degrader discovery.

摘要

单价降解剂可以增强目标蛋白与连接酶之间预先存在的表面互补性,以通过蛋白酶体诱导目标降解。在很大程度上,降解剂是偶然发现的,结构-活性关系(SAR)研究有限,这使得合理设计新化合物变得困难。在这里,我们讨论细胞周期蛋白K降解剂的SAR研究如何表明广泛的化合物可以稳定蛋白质-蛋白质相互作用以诱导降解,以及它如何为进一步发现单价降解剂奠定基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验